Search the Newsreel

How (ADXN) Movements Inform Risk Allocation Models

This article analyzes Addex Therapeutics Ltd (NASDAQ: ADXN), highlighting a positive near-term sentiment but broader weak alignment. It presents an exceptional 60.0:1 risk-reward setup targeting a 20.6% gain against a 0.3% risk. The article outlines institutional trading strategies, including position trading, momentum breakout, and …

Assetmark Inc. Trims Stock Holdings in Toll Brothers Inc. $TOL

Assetmark Inc. reduced its stake in Toll Brothers Inc. by 6% in the second quarter, selling 11,495 shares but still holding 179,605 shares valued at approximately $29.6 million. Despite insider selling by COO Robert Parahus and Chairman Douglas C. Yearley, other institutional investors significantly …

Citizens & Northern (NASDAQ:CZNC) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded Citizens & Northern (NASDAQ:CZNC) to a "strong-buy" rating. This follows other upgrades from Weiss Ratings and Zacks Research, although the overall analyst consensus remains "Hold" with a $23.50 target price. The company recently reported strong quarterly earnings of $0.79 per …

MGO One Seven LLC Sells 7,698 Shares of Toll Brothers Inc. $TOL

MGO One Seven LLC significantly reduced its stake in Toll Brothers Inc. (NYSE:TOL) by selling 7,698 shares, cutting its holdings by 70.4%. Despite this, Toll Brothers surpassed quarterly earnings expectations with an EPS of $2.72 and revenue of $2.53 billion, even as revenue declined …

Milford Funds Ltd. Sells 19,252 Shares of Toll Brothers Inc. $TOL

Milford Funds Ltd. has reduced its stake in Toll Brothers Inc. (NYSE:TOL) by selling 19,252 shares, retaining 335,735 shares valued at approximately $55.3 million. This comes as institutional investors collectively own 91.76% of the company, and several company executives, including COO Robert Parahus and …

C4 Therapeutics (CCCC) gains 6.9% disclosed stake from Squadron Master Fund

Squadron Master Fund LP and related entities have disclosed a 6.9% beneficial ownership stake in C4 Therapeutics (CCCC), totaling 7,600,000 shares. This includes 7,200,000 common shares and 400,000 shares underlying currently exercisable long call options. The filing indicates shared voting and dispositive powers among …

Welch Group LLC Buys 4,089 Shares of The Sherwin-Williams Company $SHW

Welch Group LLC increased its stake in The Sherwin-Williams Company (NYSE:SHW) by 15.2% in the second quarter, bringing its total holdings to 30,991 shares valued at $10.67 million. Other institutional investors also adjusted their positions in Sherwin-Williams, which maintains a "Moderate Buy" consensus rating …

Dockside LLC Takes $2.84 Million Position in Southern Company (The) $SO

Dockside LLC recently acquired 29,642 shares of Southern Company, valued at approximately $2.84 million, establishing a new position in the utility provider. This move is part of broader institutional investor activity, with entities like Norges Bank and Capital World Investors also making significant investments …

Value Partners Investments Inc. Reduces Holdings in Thermo Fisher Scientific Inc. $TMO

Fischer Medical Ventures consolidated net profit declines 22.02% in the June 2026 quarter

Archer Aviation Has $6.9 Million of Revenue. It's Buying a Boeing Business With More Than $200 Million.

Archer Aviation (NYSE: ACHR) is buying Boeing's (NYSE: BA) Wisk Aero, Insitu, and SkyGrid subsidiaries, and the price is a piece of itself. At closing, Archer will issue Boeing new stock equal to 19.75% of its shares outstanding just before the deal completes -- …

Protara Therapeutics (NASDAQ:TARA) Downgraded to Strong Sell Rating by Wall Street Zen

Wall Street Zen has downgraded Protara Therapeutics (NASDAQ:TARA) from a "sell" to a "strong sell" rating, despite a broader analyst consensus of "Moderate Buy" with an average price target of $26.25. The company's shares were trading at $3.97, near their 52-week low, after reporting …

Wedge Capital Management L L P NC Buys Shares of 128,845 Theravance Biopharma, Inc. $TBPH

Wedge Capital Management L L P NC recently acquired 128,845 shares of Theravance Biopharma (NASDAQ:TBPH) worth approximately $2.19 million, now owning about 0.25% of the company. Institutional investors hold 99.10% of TBPH, despite the company reporting an adjusted loss and missing revenue expectations in …

Security National Bank Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO

Security National Bank increased its stake in Thermo Fisher Scientific Inc. (TMO) by 18.5% in the second quarter, bringing its total holdings to 14,095 shares valued at approximately $7.1 million. The article also notes that institutional investors own 89.23% of TMO, and analysts generally …

Bryn Mawr Trust Advisors LLC Purchases Shares of 5,789 Hershey Company (The) $HSY

Bryn Mawr Trust Advisors LLC recently acquired 5,789 shares of Hershey Company stock, valued at approximately $1,016,000, marking a new position for the institutional investor. Other firms like Syon Capital LLC, Haverford Trust Co, and Larson Financial Group LLC also increased their holdings in …

Sphere 3D Corp. Q2 2026: Revenue $2.45M, Net loss $(13.83)M, EPS $(2.68) — 10-Q Summary

Sphere 3D Corp. reported its Q2 2026 financial results, with revenue declining to $2.45M from $3.02M year-over-year, and a net loss of $(13.83)M compared to a net income of $1.67M in Q2 2025. Diluted EPS also fell to $(2.68) from $0.60. The company highlighted …

Candel Therapeutics, Inc. (NASDAQ:CADL) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Candel Therapeutics (NASDAQ:CADL) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $19.29, significantly above its current trading price of $11.72. Despite recent insider share sales and a larger-than-expected quarterly loss of $0.52 per share, analysts maintain …

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Enliven Therapeutics (NASDAQ:ELVN) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $72.67. This comes despite the company reporting a wider-than-expected quarterly loss of $0.49 per share. Recent insider selling, including a director's $9.6 million sale, has …

BIP Wealth LLC Purchases Shares of 31,963 Southern Company (The) $SO

BIP Wealth LLC recently acquired 31,963 shares of Southern Company (NYSE:SO) valued at approximately $3.06 million during the second quarter. Other institutional investors also adjusted their positions in the utilities provider, which reported strong quarterly earnings, beating analyst estimates with $1.13 EPS. Southern Company …

KLRA Price Today: Kailera Therapeutics, Inc. Stock Price, Quote & Chart | MEXC

This article provides current stock information for Kailera Therapeutics, Inc. (KLRA), including its real-time price, key market data like market cap and trading volume, and historical performance trends. It details how to buy KLRA stock on the MEXC exchange and offers an overview of …

Cornerstone Capital Inc. Takes $4.81 Million Position in Southern Company (The) $SO

Cornerstone Capital Inc. recently acquired 50,301 shares of Southern Company (NYSE:SO) valued at approximately $4.81 million, marking a new position for the investment firm. Despite this, analysts generally hold a "Hold" rating for Southern Company, with an average price target of $100.09. The company …

Empowered Funds LLC Boosts Stock Position in The Sherwin-Williams Company $SHW

Empowered Funds LLC significantly increased its stake in The Sherwin-Williams Company (NYSE:SHW) by 143.6% in the first quarter, now owning shares valued at $8.67 million. Several other institutional investors also adjusted their positions, with overall institutional ownership at 77.67%. The company recently reported strong …

Silence Therapeutics closes $201.3M public offering By Investing.com

Silence Therapeutics plc (NASDAQ:SLN) has successfully closed an underwritten public offering, raising approximately $201.3 million. The offering included 14,907,407 American Depositary Shares at $13.50 per ADS, with underwriters fully exercising their option for additional shares. The gross proceeds will support the clinical-stage biotechnology company …

Cannon Advisors Inc. Acquires New Shares in Thermo Fisher Scientific Inc. $TMO

Cannon Advisors Inc. recently purchased 3,971 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $2.12 million, making it their 17th biggest position. This acquisition comes as other hedge funds have also adjusted their holdings in TMO, while company insiders have sold a …

Canoe Financial LP Buys 148,999 Shares of Thermo Fisher Scientific Inc. $TMO

Northern Trust Corporation $NTRS Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB significantly reduced its stake in Northern Trust Corporation (NASDAQ:NTRS) by 57.2% in the second quarter, selling 41,919 shares and retaining 31,381 shares valued at approximately $5.46 million. Despite this, other institutional investors have recently acquired positions in the company, with institutional …

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Average Rating of "Moderate Buy" by Analysts

Gain Therapeutics (NASDAQ:GANX) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month price target of $7.50. The company recently reported a narrower-than-expected quarterly loss of $0.11 per share. Institutional investors hold a significant portion of GANX stock, with several firms …

Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts

Compass Therapeutics, Inc. (NASDAQ:CMPX) has received an average "Moderate Buy" rating from sixteen research firms, with an average 12-month price target of $11.77. Despite this bullish sentiment from analysts, the company's shares are trading down 0.4% at $2.25, and it reported a quarterly loss …

Vistagen Therapeutics: Runway To Fund Operations Into 2027 >VTGN

Vistagen Therapeutics (VTGN) announced a non-dilutive financing of up to $100 million with HealthCare Royalty Partners. This agreement extends the company's financial runway into 2027, allowing it to advance its late-stage clinical programs. The initial $50 million will support the Phase 3 PALISADE-2 trial …

Empowered Funds LLC Buys 45,360 Shares of Southern Copper Corporation $SCCO

Empowered Funds LLC significantly increased its stake in Southern Copper Corporation (NYSE:SCCO) by 896.1% in the first quarter, acquiring 45,360 additional shares to hold a total of 50,422 shares valued at $8.68 million. Southern Copper recently reported strong quarterly earnings, beating analyst estimates with …

ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94%

Viking Therapeutics Inc (VKTX) News, Articles, Events & Latest Updates

Are Capricor Therapeutics’ (CAPR) Rising Losses Reframing the Risk-Reward Balance of Its Pipeline Strategy?

Why Is CIFR Stock Rising Despite Q1 Earnings Miss?

Liquidity Mapping Around (APGE) Price Events

This article provides a detailed liquidity mapping analysis for Apogee Therapeutics Inc. (NASDAQ: APGE), highlighting neutral near and mid-term readings but a positive long-term bias. It outlines institutional trading strategies including long, momentum breakout, and short positions with specific entry, target, and stop-loss levels. …

T. Rowe Price Associates (VRDN) discloses 5.2% Viridian Therapeutics ownership in 13G

T. Rowe Price Associates, Inc. has disclosed a 5.2% beneficial ownership stake in Viridian Therapeutics, Inc. (VRDN) through a Schedule 13G SEC filing. As of June 30, 2026, the firm holds 5,748,426 shares of common stock, with sole voting power over 5,748,380 shares and …